ABSTRACT
PURPOSE: To describe the clinical and fluorescein angiographic appearance of cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (AIDS). METHODS: We retrospectively examined the clinical and photographic records of four patients with AIDS and cytomegalovirus retinitis who developed cystoid macular edema. RESULTS: Seven eyes of four patients with AIDS and cytomegalovirus retinitis experienced decreased vision associated with cystoid macular edema. Vitreous inflammation was mild in each patient. In all eyes, the retinitis involved zone 1, and in all but one eye, the cytomegalovirus retinitis was inactive. In one eye, the cystoid macular edema was worsened by formation of a dense juxtafoveal epiretinal membrane. CONCLUSIONS: Although infrequently recognized, cystoid macular edema can cause visual loss in patients with AIDS and cytomegalovirus retinitis. Fluorescein angiography should be considered in any patient with cytomegalovirus retinitis and unexplained visual loss.
Subject(s)
AIDS-Related Opportunistic Infections/complications , Cytomegalovirus Retinitis/complications , Macular Edema/etiology , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/pathology , Acetazolamide/therapeutic use , Adult , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antiviral Agents/therapeutic use , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , Carbonic Anhydrase Inhibitors/therapeutic use , Cytomegalovirus Retinitis/drug therapy , Cytomegalovirus Retinitis/pathology , Fluorescein Angiography , Foscarnet/therapeutic use , Fundus Oculi , Ganciclovir/therapeutic use , Humans , Ketorolac Tromethamine , Macular Edema/drug therapy , Macular Edema/pathology , Male , Retrospective Studies , Tolmetin/analogs & derivatives , Tolmetin/therapeutic use , Tromethamine/analogs & derivatives , Tromethamine/therapeutic use , Visual AcuityABSTRACT
PURPOSE: To report the successful reduction of cyclosporine dosage with adjunctive ketoconazole in a patient with birdshot retinochoriodopathy. METHOD: Case report. RESULTS: A 55-year-old woman treated with cyclosporine for birdshot retinochoroidopathy had ketoconazole (200 mg/day) added to her medical regimen. Her cyclosporine dosage was reduced to 40 mg per day from 200 mg per day, an 80% reduction. No toxic effect was observed during 12 months of follow-up nor was there progression of the birdshot retinochoroidopathy. CONCLUSIONS: Cyclosporine dosage may be reduced considerably in patients with uveitis who use adjunctive ketoconazole. The regimen appears to be safe and efficacious.
Subject(s)
Choroid Diseases/drug therapy , Cyclosporine/administration & dosage , Immunosuppressive Agents/administration & dosage , Ketoconazole/therapeutic use , Retinal Diseases/drug therapy , Chemotherapy, Adjuvant , Choroid Diseases/physiopathology , Cyclosporine/therapeutic use , Drug Therapy, Combination , Female , Humans , Immunosuppressive Agents/therapeutic use , Middle Aged , Retinal Diseases/physiopathology , Safety , Uveitis, Posterior/drug therapy , Uveitis, Posterior/physiopathologySubject(s)
Cornea/pathology , Eye Infections, Parasitic/diagnosis , Keratitis/diagnosis , Acanthamoeba/isolation & purification , Acanthamoeba Keratitis/diagnosis , Acanthamoeba Keratitis/parasitology , Acanthamoeba Keratitis/therapy , Animals , Cornea/parasitology , Corneal Transplantation , Diagnosis, Differential , Eye Infections, Parasitic/parasitology , Eye Infections, Parasitic/therapy , Humans , Keratitis/parasitology , Keratitis/therapy , Microsporida/isolation & purification , Microsporidiosis/diagnosis , Microsporidiosis/pathology , Microsporidiosis/therapyABSTRACT
PURPOSE: To describe a case of disciform keratitis in a patient with acquired immunodeficiency syndrome (AIDS) in which varicella-zoster virus was the causative agent. METHOD: Case report, Polymerase chain reaction-based assays for varicella-zoster virus, cytomegalovirus, and herpes simplex virus were used to analyze an aqueous aspirate. RESULTS: We examined a 41-year-old man with AIDS but without a history of varicella-zoster virus dermatitis who had disciform corneal edema in his left eye. Varicella-zoster virus was detected by a polymerase chain reaction-based assay in the aqueous of the left eye; however, neither cytomegalovirus nor herpes simplex virus DNA were detected by polymerase chain reaction-based assays. The corneal edema slowly resolved while the patient was treated with famciclovir. CONCLUSION: Varicella-zoster virus may cause disciform keratitis without a preceding skin eruption.
Subject(s)
Herpes Zoster , Keratitis/pathology , Keratitis/virology , 2-Aminopurine/analogs & derivatives , 2-Aminopurine/therapeutic use , Acquired Immunodeficiency Syndrome/complications , Adult , Antiviral Agents/therapeutic use , Corneal Edema/pathology , Corneal Edema/virology , DNA, Viral/analysis , Famciclovir , Herpes Zoster/complications , Herpes Zoster/drug therapy , Herpesvirus 3, Human/genetics , Humans , Male , Polymerase Chain ReactionABSTRACT
PURPOSE: To describe a case of acute retinal necrosis syndrome in which a polymerase chain reaction-based assay provided evidence for cytomegalovirus as the causative agent of the syndrome. METHODS: Polymerase chain reaction-based assays were used to analyze a vitreous aspirate from a 70-year-old man with acute retinal necrosis syndrome. The specimen was tested for cytomegalovirus, varicella-zoster virus, and herpes simplex virus type 1 and type 2. RESULTS: The polymerase chain reaction assay for cytomegalovirus was positive, and polymerase chain reaction assays for varicella-zoster virus and herpes simplex virus type 1 and type 2 were negative. CONCLUSION: Cytomegalovirus may be a causative agent of acute retinal necrosis syndrome.
Subject(s)
Cytomegalovirus Infections/complications , Retinal Necrosis Syndrome, Acute/virology , Aged , Cytomegalovirus/genetics , Cytomegalovirus/isolation & purification , DNA, Viral/analysis , Humans , Male , Polymerase Chain ReactionABSTRACT
PURPOSE: To describe a case of microsporidial keratoconjunctivitis in a patient without human immunodeficiency virus (HIV) infection. METHODS: Case report. An epithelial corneal scraping from a woman with chronic bilateral keratoconjunctivitis was evaluated by Giemsa stain. RESULTS: Giemsa stain of an epithelial corneal scraping disclosed intracellular and extracellular spores characteristic of microsporidia. An HIV enzyme-linked immunosorbent assay (ELISA) test was negative. The signs and symptoms of the bilateral keratoconjunctivitis resolved after treatment with albendazole. CONCLUSION: Microsporidia may cause a chronic epithelial keratoconjunctivitis in the absence of HIV infection.
Subject(s)
Epithelium, Corneal/parasitology , Eye Infections, Parasitic/etiology , HIV Seronegativity , Keratoconjunctivitis/parasitology , Microsporida/isolation & purification , Microsporidiosis/etiology , Adult , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , Eye Infections, Parasitic/drug therapy , Eye Infections, Parasitic/pathology , Female , Humans , Keratoconjunctivitis/drug therapy , Keratoconjunctivitis/pathology , Microsporidiosis/drug therapy , Microsporidiosis/pathology , Visual AcuityABSTRACT
Two different monoclonal antibodies to the Thy-1 antigen, T11D7 and 2G12, were used to purify and characterize retinal ganglion cells from postnatal rat retina. Although Thy-1 has been reported to be a specific marker for ganglion cells in retina, retinal cell suspensions contained several other types of Thy-1-positive cells as well. Nevertheless, a simple two-step "panning" procedure allowed isolation of ganglion cells to nearly 100% purity. We found that postnatal ganglion cells differed in antigenic, morphological, and intrinsic electrophysiological characteristics, and that these properties were correlated with one another. Minor variations of this panning protocol should allow rapid, high yield purification to homogeneity of many other neuronal and glial cell types.
